Cargando…

Coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study

OBJECTIVE(S): To investigate the efficiency of a novel series of coumarin derivatives bearing benzoheterocycle moiety as novel cholinesterase inhibitors. MATERIALS AND METHODS: Different 7-hydroxycoumarin derivatives were synthesized via Pechmann or Knoevenagel condensation and conjugated to differe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirbod, Kimia, Jalili-baleh, Leili, Nadri, Hamid, ebrahimi, Seyed esmaeil Sadat, Moradi, Alireza, Pakseresht, Bahar, Foroumadi, Alireza, Shafiee, Abbas, Khoobi, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569448/
https://www.ncbi.nlm.nih.gov/pubmed/28868119
http://dx.doi.org/10.22038/IJBMS.2017.8830
_version_ 1783258992652320768
author Hirbod, Kimia
Jalili-baleh, Leili
Nadri, Hamid
ebrahimi, Seyed esmaeil Sadat
Moradi, Alireza
Pakseresht, Bahar
Foroumadi, Alireza
Shafiee, Abbas
Khoobi, Mehdi
author_facet Hirbod, Kimia
Jalili-baleh, Leili
Nadri, Hamid
ebrahimi, Seyed esmaeil Sadat
Moradi, Alireza
Pakseresht, Bahar
Foroumadi, Alireza
Shafiee, Abbas
Khoobi, Mehdi
author_sort Hirbod, Kimia
collection PubMed
description OBJECTIVE(S): To investigate the efficiency of a novel series of coumarin derivatives bearing benzoheterocycle moiety as novel cholinesterase inhibitors. MATERIALS AND METHODS: Different 7-hydroxycoumarin derivatives were synthesized via Pechmann or Knoevenagel condensation and conjugated to different benzoheterocycle (8-hydroxyquinoline, 2-mercaptobenzoxazole or 2-mercaptobenzimidazole) using dibromoalkanes 3a-m: Final compounds were evaluated against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) by Ellman’s method. Kinetic study of AChE inhibition and ligand-protein docking simulation were also carried out for the most potent compound 3b. RESULTS: Some of the compounds revealed potent and selective activity against AChE. Compound 3b containing the quinoline group showed the best activity with an IC(50) value of 8.80 μM against AChE. Kinetic study of AChE inhibition revealed the mixed-type inhibition of the enzyme by compound 3b. Ligand-protein docking simulation also showed that the flexibility of the hydrophobic five carbons linker allows the quinoline ring to form π-π interaction with Trp279 in the PAS. CONCLUSION: We suggest these synthesized compounds could become potential leads for AChE inhibition and prevention of AD symptoms.
format Online
Article
Text
id pubmed-5569448
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Mashhad University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-55694482017-09-01 Coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study Hirbod, Kimia Jalili-baleh, Leili Nadri, Hamid ebrahimi, Seyed esmaeil Sadat Moradi, Alireza Pakseresht, Bahar Foroumadi, Alireza Shafiee, Abbas Khoobi, Mehdi Iran J Basic Med Sci Original Article OBJECTIVE(S): To investigate the efficiency of a novel series of coumarin derivatives bearing benzoheterocycle moiety as novel cholinesterase inhibitors. MATERIALS AND METHODS: Different 7-hydroxycoumarin derivatives were synthesized via Pechmann or Knoevenagel condensation and conjugated to different benzoheterocycle (8-hydroxyquinoline, 2-mercaptobenzoxazole or 2-mercaptobenzimidazole) using dibromoalkanes 3a-m: Final compounds were evaluated against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) by Ellman’s method. Kinetic study of AChE inhibition and ligand-protein docking simulation were also carried out for the most potent compound 3b. RESULTS: Some of the compounds revealed potent and selective activity against AChE. Compound 3b containing the quinoline group showed the best activity with an IC(50) value of 8.80 μM against AChE. Kinetic study of AChE inhibition revealed the mixed-type inhibition of the enzyme by compound 3b. Ligand-protein docking simulation also showed that the flexibility of the hydrophobic five carbons linker allows the quinoline ring to form π-π interaction with Trp279 in the PAS. CONCLUSION: We suggest these synthesized compounds could become potential leads for AChE inhibition and prevention of AD symptoms. Mashhad University of Medical Sciences 2017-06 /pmc/articles/PMC5569448/ /pubmed/28868119 http://dx.doi.org/10.22038/IJBMS.2017.8830 Text en Copyright: © Iranian Journal of Basic Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Hirbod, Kimia
Jalili-baleh, Leili
Nadri, Hamid
ebrahimi, Seyed esmaeil Sadat
Moradi, Alireza
Pakseresht, Bahar
Foroumadi, Alireza
Shafiee, Abbas
Khoobi, Mehdi
Coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study
title Coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study
title_full Coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study
title_fullStr Coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study
title_full_unstemmed Coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study
title_short Coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study
title_sort coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569448/
https://www.ncbi.nlm.nih.gov/pubmed/28868119
http://dx.doi.org/10.22038/IJBMS.2017.8830
work_keys_str_mv AT hirbodkimia coumarinderivativesbearingbenzoheterocyclemoietysynthesischolinesteraseinhibitoryanddockingsimulationstudy
AT jalilibalehleili coumarinderivativesbearingbenzoheterocyclemoietysynthesischolinesteraseinhibitoryanddockingsimulationstudy
AT nadrihamid coumarinderivativesbearingbenzoheterocyclemoietysynthesischolinesteraseinhibitoryanddockingsimulationstudy
AT ebrahimiseyedesmaeilsadat coumarinderivativesbearingbenzoheterocyclemoietysynthesischolinesteraseinhibitoryanddockingsimulationstudy
AT moradialireza coumarinderivativesbearingbenzoheterocyclemoietysynthesischolinesteraseinhibitoryanddockingsimulationstudy
AT paksereshtbahar coumarinderivativesbearingbenzoheterocyclemoietysynthesischolinesteraseinhibitoryanddockingsimulationstudy
AT foroumadialireza coumarinderivativesbearingbenzoheterocyclemoietysynthesischolinesteraseinhibitoryanddockingsimulationstudy
AT shafieeabbas coumarinderivativesbearingbenzoheterocyclemoietysynthesischolinesteraseinhibitoryanddockingsimulationstudy
AT khoobimehdi coumarinderivativesbearingbenzoheterocyclemoietysynthesischolinesteraseinhibitoryanddockingsimulationstudy